Clinical Trials Browser

OTHER × Olanzapine × Thoracic × Clear all

NCT06554613 2024-08-15

Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT03571126 2021-07-13

Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

Phase 4 Unknown

Lung Neoplasms, Vomiting